270 related articles for article (PubMed ID: 31352439)
21. The triplicated alpha-globin gene locus in beta-thalassaemia heterozygotes: clinical, haematological, biosynthetic and molecular studies.
Traeger-Synodinos J; Kanavakis E; Vrettou C; Maragoudaki E; Michael T; Metaxotou-Mavromati A; Kattamis C
Br J Haematol; 1996 Dec; 95(3):467-71. PubMed ID: 8943886
[TBL] [Abstract][Full Text] [Related]
22. Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes.
Mehta PR; Upadhye DS; Sawant PM; Gorivale MS; Nadkarni AH; Shanmukhaiah C; Ghosh K; Colah RB
Ann Hematol; 2015 Dec; 94(12):1953-8. PubMed ID: 26319530
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S
Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564
[TBL] [Abstract][Full Text] [Related]
24. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
Charoenkwan P; Teerachaimahit P; Sanguansermsri T
Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
[TBL] [Abstract][Full Text] [Related]
25. Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the
Ghosh D; Panja A; Saha D; Banerjee U; Datta AK; Basu A
Genet Test Mol Biomarkers; 2021 Aug; 25(8):563-570. PubMed ID: 34406845
[No Abstract] [Full Text] [Related]
26. Response to hydroxyurea therapy in beta-thalassemia.
Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
[TBL] [Abstract][Full Text] [Related]
27. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
[TBL] [Abstract][Full Text] [Related]
28. Alpha-thalassaemia.
Harteveld CL; Higgs DR
Orphanet J Rare Dis; 2010 May; 5():13. PubMed ID: 20507641
[TBL] [Abstract][Full Text] [Related]
29. HbF in HbE/β-thalassemia: A clinical and laboratory correlation.
Lim WF; Muniandi L; George E; Sathar J; Teh LK; Lai MI
Hematology; 2015 Jul; 20(6):349-53. PubMed ID: 25243862
[TBL] [Abstract][Full Text] [Related]
30. Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT; Cappellini MD; Kattamis A; Voskaridou E; Perrotta S; Piga AG; Filosa A; Porter JB; Coates TD; Forni GL; Thompson AA; Tartaglione I; Musallam KM; Backstrom JT; Esposito O; Giuseppi AC; Kuo WL; Miteva D; Lord-Bessen J; Yucel A; Zinger T; Shetty JK; Viprakasit V;
Lancet Haematol; 2022 Oct; 9(10):e733-e744. PubMed ID: 36007538
[TBL] [Abstract][Full Text] [Related]
31. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.
Cavazzana-Calvo M; Payen E; Negre O; Wang G; Hehir K; Fusil F; Down J; Denaro M; Brady T; Westerman K; Cavallesco R; Gillet-Legrand B; Caccavelli L; Sgarra R; Maouche-Chrétien L; Bernaudin F; Girot R; Dorazio R; Mulder GJ; Polack A; Bank A; Soulier J; Larghero J; Kabbara N; Dalle B; Gourmel B; Socie G; Chrétien S; Cartier N; Aubourg P; Fischer A; Cornetta K; Galacteros F; Beuzard Y; Gluckman E; Bushman F; Hacein-Bey-Abina S; Leboulch P
Nature; 2010 Sep; 467(7313):318-22. PubMed ID: 20844535
[TBL] [Abstract][Full Text] [Related]
32. Co-inheritance of alpha globin gene deletion lowering serum iron level in female beta thalassemia patients.
AbdulAzeez S; Almandil NB; Naserullah ZA; Al-Jarrash S; Al-Suliman AM; ElFakharay HI; Borgio JF
Mol Biol Rep; 2020 Jan; 47(1):603-606. PubMed ID: 31705350
[TBL] [Abstract][Full Text] [Related]
33. Why are hemoglobin F levels increased in HbE/beta thalassemia?
Rees DC; Porter JB; Clegg JB; Weatherall DJ
Blood; 1999 Nov; 94(9):3199-204. PubMed ID: 10556208
[TBL] [Abstract][Full Text] [Related]
34. Adrenal insufficiency is prevalent in HbE/β-thalassaemia paediatric patients irrespective of their clinical severity and transfusion requirement.
Nakavachara P; Viprakasit V
Clin Endocrinol (Oxf); 2013 Dec; 79(6):776-83. PubMed ID: 23634994
[TBL] [Abstract][Full Text] [Related]
35. Detection of germline rearrangements in patients with α- and β-thalassemia using high resolution array CGH.
Blattner A; Brunner-Agten S; Ludin K; Hergersberg M; Herklotz R; Huber AR; Röthlisberger B
Blood Cells Mol Dis; 2013 Jun; 51(1):39-47. PubMed ID: 23491071
[TBL] [Abstract][Full Text] [Related]
36. Clinical expression of a rare beta-globin gene mutation co-inherited with haemoglobin E-disease.
van Solinge WW; Lind B; van Wijk R; Hart HC; Kraaijenhagen RJ
Eur J Clin Chem Clin Biochem; 1996 Dec; 34(12):949-54. PubMed ID: 8986398
[TBL] [Abstract][Full Text] [Related]
37. Effect of alpha thalassaemia trait and enhanced gamma chain production on disease severity in beta thalassaemia major and intermedia.
Gringras P; Wonke B; Old J; Fitches A; Valler D; Kuan AM; Hoffbrand V
Arch Dis Child; 1994 Jan; 70(1):30-4. PubMed ID: 7509151
[TBL] [Abstract][Full Text] [Related]
38. Molecular, haematological and clinical studies of the -101 C --> T substitution of the beta-globin gene promoter in 25 beta-thalassaemia intermedia patients and 45 heterozygotes.
Maragoudaki E; Kanavakis E; Traeger-Synodinos J; Vrettou C; Tzetis M; Metaxotou-Mavrommati A; Kattamis C
Br J Haematol; 1999 Dec; 107(4):699-706. PubMed ID: 10606872
[TBL] [Abstract][Full Text] [Related]
39. Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan province of Southwestern China.
Zhang J; He J; Mao X; Zeng X; Chen H; Su J; Zhu B
BMJ Open; 2017 Jan; 7(1):e013367. PubMed ID: 28143837
[TBL] [Abstract][Full Text] [Related]
40. Is hemoglobin instability important in the interaction between hemoglobin E and beta thalassemia?
Rees DC; Clegg JB; Weatherall DJ
Blood; 1998 Sep; 92(6):2141-6. PubMed ID: 9731073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
